| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.41 | 0.008 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.45 | 0.008 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |